DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) is a generative artificial intelligence healthcare company focused on developing and commercializing CERVAI™, a proprietary brain health AI platform. A world first, CERVAI™ consists of a Brain Age Estimation and Brain Health Assessment tool. The Brain Age Estimation tool includes a novel electroencephalogram headset and machine-learning model. It integrates proprietary software into unified and standardized data recording protocols. The Brain Health Assessment tool generates clinician-observed measures and a brain health score. These combined allow users to be proactive in achieving their brain health goals.
Intellectual Property
Fundraising
Our website uses cookies to ensure you get the best experience. Learn more about the policy.
Are you developing and/or redesigning new green products, services, processes, and technologies that reduce environmental impact?
The i.d.e.a.™ Fund program focuses on supporting a more sustainable economy while fostering an inclusive and equitable growth in southern Ontario. Find out if you’re eligible to access up to $20,000 in matching seed funding and 30 hours of expert mentorship.
Applications are open from June 16 to July 7, 2025.
